Revenio Group Corporation Stock Exchange Release, December 18th, 2013 at 09.00 a.m. REVENIO GROUP'S FINANCIAL REPORTING IN 2014 During 2014, Revenio Group Corporation will publish the following financial reports: - Financial Statements bulletin in regard to 2013 on Wednesday, February 12, 2014 - Interim Report 1-3/2014 on Thursday, April 24, 2014 - Interim Report 1-6/2014 on Monday, August 4, 2014 - Interim Report 1-9/2014 on Tuesday, October 21, 2014 The Annual General Meeting is planned to be hold on Thursday, March 20, 2014. Annual Report for 2013 will be published on the week 9. Revenio Group Corporation Olli-Pekka Salovaara President & CEO For additional information, please contact President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520 olli-pekka.salovaara@revenio.fi www.revenio.fi DISTRIBUTION: NASDAQ OMX Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish health tech group whose core business is tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy. The widely patented Icare product family is the current cornerstone of the Group's success. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers. The Revenio Group also includes other business operations, which are grouped under the Technology and Services segment. This segment's operations have a shared global market and represent the cutting edge of technology products and services in their industry. These businesses are extremely profitable in their industries and generate positive cash flow. In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its operating margin standing at 19.4%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki. [HUG#1750414]